Cellix Bio

The company that never stops innovating and inventing

Synergix AITM powered technology

Our AI-driven analysis of large datasets has potential to transform the classic R&D pipeline into new ways of more precise target selection and accelerating multiple stages of development

Harnessing the data

Synergix AITM is pioneering a transformative new big data approach to discovery and development of treatments provides more effective precision treatments for individuals as well as a reduction in costs to our healthcare systems

Accelerating treatments

At Cellix Bio, the therapeutic lead discovery is rapid, smarter and safer, and strengthens our team and partners in achieving and translating new treatments towards the clinic

Intellectual Property

Our patent portfolio includes several issued patents and patent applications in the world’s major markets. We are constantly expanding, broadening and developing our intellectual property portfolio

What We Do

Revealing the power of AI and humanoid inventiveness to discover new therapeutics

Founded in 2014, we are the leading drug discovery and development company. We generate our own drug design data before combining the critical power of AI with the creativity of involving proprietary platform technology, Synergix AITM and expertise of our world-class scientists. This allows us to shorten the pre-clinical drug discovery stage and, in turn, substantially accelerate the delivery of new treatments to patients worldwide. By reducing the number of compounds analysed, we aim to vividly reduce the time and cost of discovering and developing new medicines. Cellix Bio balances Synergix AITM plus human creativity in the drug discovery.

Our targeted discovery process enables the creation of new markets and solutions to both old and new problems. Driven by the speed and accuracy of our platform, Synergix AITM accomplishes in months what previously took years, saving tens of millions in research and development costs. Each of our lead candidates are unique with powerful therapeutic benefits. The molecular entities that we discover are the first of their kind and patented.

Using our Synergix AITM drug discovery platform and the insights from our successful drug development and clinical data, we can identify synergistic pharmacology between bio-actives, combining them to address disease related biochemical pathways and targets. However the rubrics of drug discovery are very complex - not all are known and some are not readily describable as a restricted set of moves.

Cellix Bio intends to develop targeted therapies

Know More
Featured Box Image

Platform Technologywe have built our firm on eminent science and a profound understanding of the biology behind diseases

Read More
Featured Box Image

Intellectual Property300 international patents published, obtained 63 Composition of Matter Issued U.S Patents from the USPTO

Read More
Featured Box Image

PipelineDrugs with important functional advantages and the capability to deliver both clinical and commercial successes

Read More

Cellix Bio Therapeutic Focused Portfolio

Oncology

Welcome to a better way to Live your Life.

Know More

Ophthalmology

Welcome to a better way to Live your Life.

Know More

Neurology

Welcome to a better way to Live your Life.

Know More

Gastrointestinal

Welcome to a better way to Live your Life.

Know More

Anti-Mycotics

Welcome to a better way to Live your Life.

Know More

Metabolic Diseases

Welcome to a better way to Live your Life.

Know More

Pain and Inflammation

Welcome to a better way to Live your Life.

Know More

Dermatology

Welcome to a better way to Live your Life.

Know More

Superior in Transformation of Ideas

Building a biopharmaceutical company with selective new technologies, ideas, medicines, and insights leading to superior transformation of ideas; our core competence is to develop and commercialize therapeutic drug products with less development risk and unique benefits for patients within our therapeutic areas of focus

Know More

Therapeutic Benefits

Cellix Bio uses it’s proprietary Synergix technology to develop New Molecular Entities with novel chemical structures that target known pathophysiological pathways most likely to yield significant therapeutic benefits.

Strong Scientific Platform Synergix AITM

Using our proprietary technologies and our “Synergix AITM” scientific platform, we are developing new medicines that modulate more than one target in the disease pathway, which potentially improves efficacy and minimizes risk in the discovery and development process.

Know More

Team Work

Our team has unique scientific and entrepreneurial experience in the life science industry, including R & D management, formulation development, and business development in renowned biopharmaceutical companies.

Read More
Chrome